Firms To Watch: Intellectual property: patents (contentious and non-contentious)

Morgan, Lewis & Bockius UK LLP welcomed veteran of patent litigation Tim Powell in October 2024 from Powell Gilbert LLP following the September arrival of fellow seasoned disputes and transactions specialist and former Baker McKenzie LLP patent lead Hiroshi Sheraton. Nick Bolter heads the group.
Led by experienced life sciences disputes and AI specialist Jason Raeburn, the team at Paul Hastings LLP added ex-EIP tech patent litigator Alex Morgan to its bench in December 2024, and receives an array of multijurisdictional mandates from heavy-hitting clients.

Intellectual property: patents (contentious and non-contentious) in London

A&O Shearman

Headed up by digital, data, and tech IP transactions specialist Jim Ford, the patent-focused team in A&O Shearman‘s London office is routinely instructed by a blue-chip client roster hailing from key sectors, including the tech, life sciences, and pharma spaces. The group is adept in handling major patent litigation and enforcement work, patent-rich M&A, licensing issues, JV deals, and confidential information disputes. Rafi Allos is a litigator in the life sciences and healthcare sectors, and Gemma Barrett adds experience in chemicals litigation. Neville Cordell focuses on acting for TMT and telecoms businesses, Mark Heaney is a key contact for some of the team’s largest clients, and Marjan Noor is noted for her representation of life sciences players in critical disputes. Transactions lawyer Nigel Parker and trade secrets-focused Mark Ridgway are also on the team, alongside patent litigator Tom Edwards, hi-tech and telecoms-oriented James Fox, and Megan McMellon, who delivers advice on the commercial side.

Responsables de la pratique:

Jim Ford


Autres avocats clés:

Rafi Allos; Gemma Barrett; Neville Cordell; Mark Heaney; Marjan Noor; Nigel Parker; Mark Ridgway; Tom Edwards; James Fox; Megan McMellon; Alex Shandro; Alexandra Wyles


Les références

‘Their depth of talent across the whole range of seniority from senior partner to junior assistant is consistently high.’

‘The extremely conscientious and intelligent Marjan Noor engages very effectively with the client’s problems and has a direct hand on the issues of the case to steer it carefully. The senior associate team is very experienced, extremely hardworking, and competent in life sciences litigation.’

‘Marjan Noor’s deep involvement in cases, where she puts careful thought into the case theory and strategy to make sure that no point is left without consideration, means that clients’ cases have strong direction and leadership throughout. She understands the legal and scientific issues in complex life sciences cases and marries the two expertly.’

Principaux clients

Bayer


Sterlite Technologies


Huawei


MBDA


NXP semiconductors


Exscientia


Regeneron


Principaux dossiers


  • Advising Sterlite in a patent litigation matter against Prysmian, which alleged infringement of two of its patents relating to optical fibre cable design and seeks, among others, damages and an injunction.
  • Advising Bayer on the enforcement and defence of its patents across Europe, protecting its highest selling product, Xarelto®, a blockbuster anticoagulant medication.
  • Retained by Exscientia to advise on a range of IP collaborations.

Bird & Bird LLP

Well-versed in SEP/FRAND litigation, life sciences patent disputes before the UK courts and the UPC, managing SPCs, and a host of commercial, transactional, and investment matters, Bird & Bird LLP‘s sizeable patent team is led by tech and telecoms disputes specialist Richard Vary, Rebecca O’Kelly-Gillard, and transactions lawyer Tom Snaith. They are supported by seasoned navigator of cross-border litigation Morag Macdonald, life sciences and biotech disputes specialist Mark Hilton, pharma-focused Neil Jenkins, and Katharine Stephens, who comes recommended for running enforcement programs and IP litigation. Jae Park takes care of patents and designs from all administrative, commercial, and disputatious angles, and Toby Bond handles copyright, trade secrets, regulatory matters, and data issues, as well as patent disputes in the AI realm. Eleanor Root is experienced in patent litigation, James Pearson focuses on transactions, and Matthew Noble is noted for his expertise in SEP/FRAND issues. William Warne is another key name, alongside Jane Mutimear.

Responsables de la pratique:

Rebecca O’Kelly-Gillard; Tom Snaith; Richard Vary


Autres avocats clés:

Morag Macdonald; Katharine Stephens; Jae Park; Toby Bond; Eleanor Root; James Pearson; Matthew Noble; Tim Darvill; William Warne; Jennifer Jones; Mark Hilton; Patrick Kellher; Nicole Jadeja; Louise Sargeant; Mario Subramaniam; Jane Mutimear; Neil Jenkins; Sally Shorthose


Les références

‘Bird & Bird assisted with IP due diligence related to an M&A. Their keen understanding of the scope of the project together with their ability to get up to speed very quickly was critical. Their understanding of the technology together with their legal acumen (and speed) was impressive.’

‘Sally Shorthose – high legal acumen together with technical depth. Has the ability to distil large amounts of IP data into information that really assists in achieving the best result for the client.’

‘Richard Vary is a knowledgeable IP solicitor.’

Principaux clients

Nokia


Interdigital


Martin-Baker Aircraft Company


The Broad Institute


Dexcom


Celltrion


ZTE


CureVac


Principaux dossiers


  • Acted for Dexcom in multiple international patent infringement and revocation claims against Abbott in relation to its continuous glucose monitoring devices.
  • Acted for Interdigital in filing patent infringement actions in the UK, India, and Germany against four patents alleging infringement of its patents relating to 3G, 4G/LTE and 5G against Oppo.
  • Acting for Martin-Baker Aircraft Company in a patent action against another manufacturer of jet ejection seats.

Bristows LLP

Bristows LLP has a strong track record in the patent litigation arena, housing a team of seasoned patent experts jointly led by Andrew Bowler, who is experienced in coordinating multijurisdictional parallel litigation for clients operating across an array of innovation-based sectors; Robert Burrows, whose remit spans plant varieties, and patent and SPC cases for life sciences clients; and transaction-focused Richard Dickinson, who is well-versed in the development, exploitation, and protection of IP rights in various industries. Litigator Liz Cohen acts for clients across the UK and European courts and registries, and James Boon’s expertise applies to the intersection of IP and competition law. Dominic Adair is a key name for cross-border life sciences patent disputes, taking on litigation and ADR. Veteran of hi-tech patent litigation Myles Jelf is also in the team, alongside pharmaceuticals-focused Brian Cordery, and Matthew Warren and Claire Smith, who orchestrate complex IP transactions. Charlie French, Gregory Bacon, Naomi Hazenberg, Richard Pinckney and Rachel Mumby are further names to note.

Responsables de la pratique:

Rob Burrows; Andrew Bowler; Richard Dickinson


Autres avocats clés:

Liz Cohen; James Boon; Dominic Adair; Myles Jelf; Brian Cordery; Matthew Warren; Charlie French; Gregory Bacon; Rachel Mumby; Naomi Hazenberg; Adrien Chew; Claire Phipps-Jones; Louisa Jacobs; Richard Pinckney; Claire Smith


Les références

‘Charlie French is incredibly impressive, intelligent, and wonderful to deal with. A real asset to the Bristows partnership.’

‘Amongst the best in the UK and with a good network of partner firms to coordinate UPC cases. Young, dynamic partners with enthusiastic and able associates.’

‘Brian Cordery is highly regarded amongst all UK patent practitioners, especially for his pharmaceutical work. Rachel Mumby and Adrian Chew are both excellent.’

Principaux clients

Novartis Pharma AG


Sandoz


Siemens Gamesa Renewable Energy


Philips


Teva Pharmaceutical Industries


Mara Renewables Corp.


Panasonic


Prysmian Group


Scientific Drilling International, Inc.


Genentech


Touchlight Genetics Ltd.


Pharma Mar


3M


GSK


Diageo


AstraZeneca


De Beers


LifeArc


UCL Business


The Wellcome Sanger Institute


Verdiva Bio


Nxera Pharma


Principaux dossiers


  • Advised Touchlight Genetics in the defence against one of its founders in English patent litigation over entitlement to patents.
  • Advised Panasonic in SEP patent infringement proceedings against Xiaomi and OPPO in the UK, including FRAND advice and rate determination, and in parallel proceedings and coordination with UPC and Germany.
  • Advised AstraZeneca on a global collaboration with Harbour BioMed to discover and develop multi-specific antibodies for immunology, oncology and more.

Kirkland & Ellis International LLP

Described by one client as ‘leaders in UK patent practice,’ Kirkland & Ellis International LLP is frequently tasked by globally active clients with representing them in UK SEP/FRAND licensing disputes, with the firm marshalling its international network to oversee parallel proceedings in Europe, Asia and the Americas. ‘Force of nature’ Nicola Dagg takes the lead on such disputes, with expertise in both the pharmaceutical and tech sectors. She heads the firm’s patent litigation efforts alongside Daniel Lim, whose practice is centred on life sciences patent disputes, and Steven Baldwin, whose focus lies in SEP/FRAND issues in the telecoms sector. Emma Flett heads the practice’s transactional arm, taking the lead on the IP aspects of multi-jurisdictional public and private transactions, with experience handling deals in sectors as diverse as software, pharmaceuticals and energy, among others. Jin Ooi adds further contentious expertise across matters involving companies in the pharmaceutical and chemical industries.

Responsables de la pratique:

Nicola Dagg; Daniel Lim; Steven Baldwin; Emma Flett


Autres avocats clés:

Jin Ooi


Les références

‘Kirkland & Ellis are the leaders in UK patent practice. Their team is excellent at all levels. They are not afraid to push boundaries and develop new law, to their clients’ advantage. Their ability to tackle a range of different subject matter is truly impressive.’

‘Nicola Dagg is truly excellent, you couldn’t have somebody better on your side. Daniel Lim is intelligent, commercially focused and great to work with. He will work at a problem in an innovative way to get the best result for his clients. Jin Ooi is a brilliant legal and strategic mind. Excellent on disputes with multi-national dimensions. Steven Baldwin is wonderful to work with and incredibly bright.’

‘Absolute powerhouse on FRAND litigation in the UK, no firm has as much as experience as the K&E team on FRAND issues.’

Principaux clients

Advanced Bionics


Alcon


Astellas


Boehringer Ingelheim


Intel


Lattice


Lenovo


Meril Life Sciences


Pfizer


Pharmathen


Samsung Electronics


Thales


Xiaomi


Principaux dossiers


  • Represented Xiaomi in its defence of global enforcement proceedings launched by Panasonic in the UPC and the UK, Germany and China, obtaining declarations from the Court of Appeal that Panasonic should grant Xiaomi a short-term interim license, pending the FRAND trial.
  • Represented Lenovo and Motorola Mobility in SEP/FRAND proceedings with Ericsson, with parallel proceedings in the UK, the US, Brazil and Colombia, concerning global licensing royalty rates.
  • Represented Astellas Pharma Europe Ltd. and The Regents of the University of California in defeating validity challenges brought by multiple generic companies on patents covering Xtandi.

Pinsent Masons LLP

Pinsent Masons LLP’s patents team counsels clients operating in the full array of patent-intensive industries, advising on R&D and patent licensing agreements, and other IP-rich transactions as well as handling generics and biosimilars litigation and revocation proceedings and UPC disputes. Tom Nener, based between Birmingham and London, leads the group, which consists of Charlotte Weekes, who specialises in acting for life sciences clients, James Marshall, who focuses on FRAND-related actions, and Christopher Sharp, who navigates a varied patent litigation caseload. Catherine Drew‘s experience spans patent and regulatory and contentious matters. Patent attorney and registered UPC representative Kristina Cornish focuses on biopharma work, and Gareth Morgan litigates across various courts. Gina Bicknell, Mark Marfé, and Tracey Roberts are further key contacts. Clare Tunstall left the practice in November 2024.

Responsables de la pratique:

Tom Nener


Autres avocats clés:

Charlotte Weekes; James Marshall; Christopher Sharp; Catherine Drew; Kristina Cornish; Gareth Morgan; Gina Bicknell, Mark Marfé; Tracey Roberts


Les références

‘Patent litigation team is top-notch.’

‘Catherine Drew is at the forefront of patent litigation. One of the best in the industry. Great strategic advice. Clear and cuts straight to the key issues. Highly responsive and proactive.’

‘Gina Bicknell was amazing – she kept following up with us on the deal.’

Principaux clients

Teva Pharmaceutical Industries


Accord Healthcare


Sandoz AG, Sandoz Limited


Fresenius Kabi


Oppo Mobile


Ericsson


Advanced Cell Diagnostics


Flynn Pharma


Formycon


Bioeq AG


Safran Seats


Abbott Product Operations AG


STADA Arzneimittel AG


Sum and Substance


Hikma Pharmaceuticals


Klinge Biopharma


CSL Limited


C4X Discovery Limited


RedX Pharma


Medherant Limited


Volition Rx


AdvanSix


Principaux dossiers


  • Acted for OPPO before the England & Wales High Court in patent infringement and FRAND-related proceedings initiated by Panasonic.
  • Advised and represented, jointly, Sandoz AG, Sandoz Limited, and Accord in revocation proceedings before the UK Patents Court and Court of Appeal in respect of a dosing regime patent concerning the product Rivaroxaban (Xarelto).
  • Supported Intas Pharmaceuticals Ltd on its global licensing and co-development agreement with Xbrane Biopharma AB for Xbrane’s Nivolumab biosimilar candidate, Opdivo®.

Powell Gilbert LLP

Powell Gilbert LLP’s patent team, which includes a number of UPC representatives, works across offices in London and Dublin, acting for an impressive client roster operating in the patent-heavy sectors of life sciences, biotech, medical tech, and more. Veteran patent litigation expert Penny Gilbert leads the team alongside Simon Ayrton, a key figure in FRAND disputes who also advises clients on strategy and parallel proceedings. Zoë Butler is experienced in handling multijurisdictional disputes and technology transfer cases, and Bethan Hopewell and Joel Coles specialise in life sciences work. Siddharth Kusumakar leverages a technical background in immunology to represent clients before various courts, and Ari Laakkonen focuses on disputes and licensing in the electronics, IT, and telecoms spaces. Further key names include versatile litigators Tom Oliver and Alex Wilson, life sciences-oriented Tess Waldron, Tim Whitfield, whose broad remit includes various international contentious patent matters, and Rajvinder Jagdev, a key contact for TMT clients. Bryce Matthewson’s caseload comprises medical devices and pharma-related proceedings, barrister Callum Beamish-Lacey handles damages inquiries, and Claire Robinson is well-versed in tech disputes. FRAND litigator Richard Fawcett’s knowledge spans microelectronics, engineering, and nanoscience, and Daniel Down is another main player in the practice, along with Pete Damerell.

Responsables de la pratique:

Penny Gilbert; Simon Ayrton


Autres avocats clés:

Zoë Butler; Bethan Hopewell; Joel Coles; Siddharth Kusumakar; Ari Laakkonen; Tom Oliver; Alex Wilson; Tess Waldron; Tim Whitfield; Rajvinder Jagdev; Bryce Matthewson; Callum Beamish-Lacey; Claire Robinson; Richard Fawcett; Daniel Down; Pete Damerell


Les références

‘First-class patent litigation team for UK and Europe. Also very good strategic advisors for global patent litigation.’

‘Alex Wilson is a brilliant strategist with a high EQ and strong ability to work with local counsel in global litigation.’

Principaux clients

BioNTech


Edwards Lifesciences


ASUSTek Computer Inc.


Tesla


ZTE


Glenmark


DSM


Biogen Inc


Samsung Bioepis


NadorCott / Nador Cott Protection S.A.S.


Saint Gobain


City Glass and Glazing Private Limited


AIM Sport


Philip Morris International


Bhagat Textile Engineers


Ocado


Garrett Motion SARL


IDnow


Principaux dossiers


  • Acting for BioNTech against Moderna in actions related to the mRNA technology and the specific antigens and delivery formulations for the SARS-CoV-2 vaccines.
  • Representing Edwards Lifesciences in an international patent dispute with Meril Life Science in respect of Meril’s Myval, Myval Octacor, and Myval Octapro transcatheter heart valve systems.
  • Acting for Tesla against InterDigital & Avanci in FRAND 5G patent litigation.

Simmons & Simmons

With vast experience representing a prestigious client base in various types of patent disputes, the team at Simmons & Simmons turns its hand to matters in the life sciences, telecoms, tech, engineering and healthcare sectors, devising IP strategies and negotiating high-value R&D, collaboration, and other commercial agreements for clients in innovative industries. Practice head Kevin Cordina is noted for his expertise in patent prosecution and contentious matters, and Scott Parker is a key name for pharma and biotech litigation. On the transactional side are licensing, collaborations, and regulatory specialist Michael Gavey, and Angus McLean, who focuses on emerging technologies. Priya Nagpal‘s practice encompasses patent disputes connected to disruptive technologies. Lydia Torne is noted for licensing advice in the health, medical tech, and life sciences space, and Elsa Glauert takes on contentious work in the same sectors. Joel Smith joined from Hogan Lovells International LLP in 2024.

Responsables de la pratique:

Kevin Cordina


Autres avocats clés:

Scott Parker; Michael Gavey; Angus McLean; Priya Nagpal; Lydia Torne; Elsa Glauert; Joel Smith


Les références

‘I have been working with Simmons & Simmons for a number of years. When it comes to digital health issues, like IP, data protection, and related rules and legislation, Simmons  & Simmons really know their stuff.’

‘Priya Nagpal is my key contact at Simmons. Priya is a strategic and insightful IP litigator. Priya has great experience and insight, and consistently devises sophisticated and effective strategies to navigate intricate IP challenges. Moreover, her collaborative nature makes her a delight to work with. Priya is backed by an excellent team.’

‘The team puts effort into learning and understanding the priorities of us as a client, which makes it much easier to initiate new tasks and heightens the value of the work provided.’

Principaux clients

Boston Scientific Corporation


Samsung Bioepis


Apple


GSK


Amgen


AstraZeneca


Merck Sharp & Dohme


J&J


Alnylam


Roche


Regeneron


Pfizer


Biogen


Boehringer Ingelheim


Novo Nordisk


Novartis


Randox


Ascendis Pharma


Cooper Consumer Health


Danaher


Insulet


Whoop


Covis


Toyota


Sibio


Principaux dossiers


  • Advised Ascendis Pharma on its exclusive worldwide licence to Novo Nordisk for the TransCon technology platform to develop, manufacture and commercialise Novo Nordisk’s proprietary products in metabolic diseases.
  • Advised GSK in connection with the negotiation and drafting of its collaboration agreement with Muna Therapeutics to identify, develop and commercialise drug targets for the treatment of Alzheimer’s Disease.
  • Advised Samsung Bioepis with the UK patent revocation action and broader European strategy concerning pre-filled syringes of Lucentis/Ranibizumab.

Taylor Wessing LLP

With a multinational client roster, Taylor Wessing LLP‘s patent outfit is well-equipped to guide innovative clients through disputes, acting before domestic courts and the UPC, as well as helping patent owners maximise the value of their assets. Practice head Nigel Stoate has led on crucial patent litigation cases for some of the world’s foremost biotech companies, supported by ‘exceptional litigator’ Matthew Royle, a key contact for an array of instructions, spanning patent litigation, SPCs, paediatric extensions, and opinion and regulatory work. Mike Washbrook is a name to note for SEP/FRAND litigation, an area where Tom Foster is also experienced. Xuyang Zhu‘s practice covers contentious and transactional IP work in the media and tech sectors, and Christopher Thornham advises on freedom to operate issues, launches, litigation, and FRAND licensing disputes, while Andrew Payne, who has a background in medicinal chemistry, routinely acts for life sciences companies in cross-border disputes. Another key figure is Amanda Ebbutt, who handles litigation and commercial matters involving life sciences, healthcare, and technology patents.

Responsables de la pratique:

Nigel Stoate


Autres avocats clés:

Matthew Royle; Mike Washbrook; Tom Foster; Xuyang Zhu; Christopher Thornham; Andrew Payne; Amanda Ebbutt


Les références

‘Excellent and full-service IP team with strength across all areas of patents. Committed, great attention to detail in the preparation of cases and evidence. Best for « bet the business » litigation, which requires a broad, strategic and European perspective.’

‘Nigel Stoate is a first-rate captain of the team, is encouraging to junior staff, and has first-rate client management skills. Matt Royle is an exceptional litigator on technical patent matters. Understated with razor-sharp intelligence and preparation. One of the safest but toughest hands in the industry, and always a pleasure to work with. Always prepared to put in the work in an efficient way.’

‘A dynamic and innovative team.’

Principaux clients

Pfizer


Abbott


Viatris


Glenmark


OPPO


Ericsson


Cumulus Oncology Limited


Antiverse Limited


Principaux dossiers


  • Acting for Pfizer in the UK in patent revocation proceedings against uniQure concerning Pfizer’s and uniQure’s rival gene therapy products for the treatment of haemophilia B.
  • Acting for Abbott Laboratories co-ordinating European patent litigation against Dexcom in respect of continuous glucose monitoring (CGM) devices.
  • Representing Viatris in a revocation action against AstraZeneca regarding a medication used to treat type-2 diabetes.

Carpmaels & Ransford LLP

A key resource for heavyweights in the life sciences sector, Carpmaels & Ransford LLP is best known for litigating major drug, chemicals, tech, and other patent disputes across the UK courts and the UPC. The group is also well-versed in IP-rich transactions, EPO oppositions, and patent prosecution strategy. Jointly led by disputes lawyer Ian Kirby, Hugh Goodfellow, and transactions-focused Jake Marshall, the team includes life sciences specialist Jennifer Antcliff, who acts for clients in patent and SPC litigation, and Simon Llewellyn, who handles cross-border disputes in the healthcare sector. Agathe Michel-de Cazotte‘s expertise includes coordinating parallel litigation and UPC-related work, and Craig Lumb comes recommended for life sciences disputes.

Responsables de la pratique:

Ian Kirby; Hugh Goodfellow; Jake Marshall


Autres avocats clés:

Jennifer Antcliff; Simon Llewellyn; Agathe Michel-de Cazotte; Craig Lumb; Daniel Wise; Paul Kaufman; David Wilson


Les références

‘Excellent team leading the UK firms in UPC work. Fantastic synergy between the prosecution experts and the litigators.’

‘Ian Kirby leads the team brilliantly. Always innovative. Jenny Antcliff is up and coming, as is Simon Llewellyn. Some brilliant new recruits.’

‘Carpmaels & Ransford are without a doubt one of the best patent litigation practices in Europe. They have an exceptional team with vast experience in coordinating patent and SPC-related disputes across Europe. They have strong patent litigation, prosecution, and regulatory teams, and are uniquely positioned to advise clients on strategy and litigation across the UK Courts and the EPO, as well as before the UPC.’

Principaux clients

Sanofi


Johnson & Johnson


Takeda Pharmaceuticals


Janssen Biotech


Regerneron Pharmaceuticals


Novartis


Curio BioSciences


CSL


bioMérieux


Gilead


Vertex


Ascendis Pharma


Principaux dossiers


  • Secured a UPC revocation decision of the Central Division UPC for Sanofi and Regeneron.
  • Defending and enforcing the patents that protect Johnson & Johnson’s product, Stelara.
  • Acting for Takeda to lead and coordinate an SPC and patent matter in preparation for litigation concerning ELVANSE® across Europe.

CMS

The patent offering at CMS is co-led by Sarah Hanson and litigator Caitlin Heard, and offers a range of contentious and non-contentious services to major players in patent-heavy industries. Participants in the emerging area of SEP and FRAND, the group is also well-versed in complex life sciences litigation, plant breeders’ rights disputes, patent commercialisation strategies, and major IP-based transactions in the tech and energy sectors, a workflow where Joel Vertes is a key name. He also leads the charge on the team’s patent monetisation offering. The bench includes seasoned patent disputes specialist Mark Shillito, and Fionnuala Rice, who is experienced across a variety of contentious and non-contentious instructions. Toby Sears departed for Jones Day in October 2024.

Responsables de la pratique:

Caitlin Heard; Sarah Hanson


Autres avocats clés:

Joel Vertes; Mark Shillito; Fionnuala Rice


Principaux clients

Microsoft


Hydra well


Mayborn (Tommee Tippe)


Estar Medical Ltd.


Sainsbury’s


Stockmeier


Principaux dossiers


  • Retained by Microsoft Corporation to defend a claim of patent infringement in the UK High Court.
  • Defending Sainsbury’s in proceedings relating to alleged infringement of a plant breeders’ right owned by Nador Cott Protection S.A.S.
  • Defending Stockmeier in a claim for patent infringement in the UK.

EIP

Specialists in tech patents, EIP is best known for its Standard Essential Patent and FRAND litigation expertise, with experience acting in a substantial portion of the key cases in the area. The team also advises clients in relation to transactional and regulatory matters, and handles IP-rich investments and M&A. Litigators Andrew Sharples and Robert Lundie Smith lead the group in conjunction with non-contentious practitioner Mark Lubbock. ‘Pro litigator’ Gary Moss brings over three decades of complex tech patent expertise to the group, and Kathleen Fox Murphy is particularly well-versed in obtaining interim injunctions and handling the associated damages disputes. Catherine Howell is another highly recommended name.

Responsables de la pratique:

Andrew Sharples; Robert Lundie Smith; Mark Lubbock


Autres avocats clés:

Kathleen Fox Murphy; Catherine Howell; Gary Moss


Les références

‘Rob Lundie Smith runs an exceptional telecoms, computer system, and high technology patent litigation team. They have the capability to deal with the most complex and demanding patent litigation. They also handle other IP matters with great care, insight, and skill.’

‘Rob Lundie Smith is one of the leading high technology IP litigation partners in London. He manages the requirements of demanding clients and demanding litigation well. He has deep and careful insight into technology and the strategic issues which arise in complex technology litigation, including in relation to cloud computing systems and AI. He has a deep knowledge of Standard Essential Patents (SEP) and FRAND litigation.’

‘Catherine Howell is an experienced and organised associate who is able to manage complex litigation and applications in her own right. A rising star.’

Principaux clients

Nokia Technologies Inc


Alcatel Lucent


Optis


Throughputer


Amgen


Principaux dossiers


  • Representing Alcatel Lucent in its patent claim against Amazon for infringement of three of its patents, as well as representing Nokia in Amazon’s counterclaim against Nokia.
  • Representing PanOptis in proceedings in the High Court against Apple, relating to setting the terms of a FRAND licence for Optis’ cellular standard essential patent portfolio.
  • Represented ThroughPuter in its UK litigation against Microsoft and the assertion of ThroughPuter’s patent against aspects of Microsoft’s UK data centres.

Herbert Smith Freehills Kramer LLP

The patent group at Herbert Smith Freehills Kramer LLP counsels clients in relation to a range of IP-heavy transactions and R&D deals, coordinates cross-border litigation involving the UPC, and is particularly experienced in litigating disputes for innovators in the pharmaceutical sector. The team, which works under the leadership of life sciences specialist Sebastian Moore, is also equipped to advise a range of clients on SPCs, hi-tech patent litigation, and more. Andrew Moir is a key contact for digital and tech patent matters, including SEP and FRAND litigation, and Andrew Wells is a highly experienced litigator across various innovation-intensive industries. Emily Bottle, who pivots between the firm’s London and Milan offices, handles life sciences disputes, and Jonathan Turnbull specialises in disputes stemming from R&D agreements. Emma Sherratt‘s remit includes patent validity and freedom-to-operate work in the pharma and life sciences sectors, and George McCubbin is involved in non-contentious and contentious pharma matters. Monika Klajn and Priyanka Madan are further names to note.

Responsables de la pratique:

Sebastian Moore


Autres avocats clés:

Andrew Moir; Andrew Wells; Emily Bottle; Jonathan Turnbull; Emma Sherratt; George McCubbin; Monika Klajn; Priyanka Madan; Emily Bottle


Les références

‘They are highly skilled.’

‘Emily Bottle and Sebastian Moore are both excellent to work with.’

‘This practice is unique in being able to call upon a large network of high-quality attorneys with different skill sets and specialities. This means they can hit the ground running in any kind of dispute, including technically-focused and legally-focused disputes, and provide instant, effective advice.’

Principaux clients

Seoul Semiconductor


R2 Semiconductor


Gilead Sciences


Takeda


Roche


AbbVie


British American Tobacco (BAT)


Sanofi


MT Realtime Live


Games Global


Principaux dossiers


  • Acted for Millennium Pharmaceuticals and its licensee Johnson & Johnson in the pan-European defence of Velcade’s market exclusivity (bortezomib), a drug used to treat multiple myeloma and mantle cell lymphoma.
  • Representing MT RealTime Live Ltd against Playtech Software Limited in two sets of UPC patent proceedings concerning interactive live gaming, and in related proceedings in the UK High Court concerning trade secrets and confidential information.
  • Acting for Roche in the defence of English High Court proceedings brought by Accord Healthcare seeking revocation of two patents protecting Roche’s Herceptin subcutaneous formulation.

Hogan Lovells International LLP

Paul Brown, a go-to for clients in the electronics and medical devices fields and ‘doyen of phone litigation’, heads up the patents offering at Hogan Lovells International LLP. The practice has a wide bench of lawyers with experience in disputes and transactions in innovation-based sectors, from pharmaceuticals and life sciences, to chemicals, machinery, and tech, with cases related to SEPs and FRAND being a key workflow. Seasoned practitioner Stephen Bennett is noted for leading various high-stakes disputes across several sectors, and Daniel Brook is sought out for representation in pharmaceutical patent disputes. Multijurisdictional litigation specialist Katie McConnell and Stella Wong are also key players in the team. Dominic Hoar and Ian Moss are recommended for life sciences, tech, and telecoms work.

Responsables de la pratique:

Paul Brown


Autres avocats clés:

Stephen Bennett; Daniel Brook; Katie McConnell; Stella Wong; Dominic Hoar; Ian Moss; Jemma Trainor; Imogen Ireland


Les références

‘Stephen Bennett is very highly regarded by all his peers. Paul Brown is a doyen of phone litigation. Daniel Brook is very careful and competent. Katie McConnell is also excellent. Highly rated associates include Imogen Ireland and Ian Moss.’

‘Hogan Lovells have a hugely experienced IP practice. They cover all the major areas (life sciences, telecoms, medical devices etc.). The team is great to work with – everyone is friendly and there is a no-nonsense approach that pervades the team.’

‘Stephen Bennett is hugely experienced. Unflappable, down to earth and urbane – he is as cool as a cucumber even when the pressure comes on in litigation.’

‘Dan Brook is technically very adept and a real street fighter when it comes to litigation. He is also not afraid to roll up his sleeves and get stuck in. Paul Brown is hugely experienced in telecoms litigation, especially those relating to FRAND patents and issues. He also has a great nose for the best point in a case. Katie McConnell is another one with huge telecoms and FRAND experience. Jemma Trainor and Imogen Ireland are very good with the detail of telecoms cases. Stella Wong is excellent on life sciences.’

‘Paul Brown and the team are really excellent at standard essential patent disputes – they are strategic and smart, they write well, and they have very good knowledge of the space. They were a pleasure to work with.’

‘Hogan Lovells have an extremely impressive and committed team of patent experts, especially in the field of FRAND litigation. The effort and expertise deployed to achieve a successful outcome for their client were nothing short of extraordinary.’

‘Paul Brown – Paul is a ferociously intelligent lawyer and a tenacious litigator. He has a really great ability to understand the fine details of a case whilst also formulating and implementing a clear overall strategy for success. Jemma Trainor is one of the best Senior Associates with whom I have worked in the IP sector. She is hugely knowledgeable about SEPs and FRAND litigation, very bright indeed, and is a natural litigator. Katie McConnell is a natural team leader in large and valuable litigation, with very considerable experience of SEPs and FRAND. I have seen and value her ability to manage high-pressure situations in high-stakes litigation effortlessly.’

‘Stephen Bennett gets it done. Dan Brook knows the answers.’

Principaux clients

Cisco


Amazon


Guangdong OPPO Mobile Telecommunications Corp. Ltd


Astellas Pharmaceuticals


Eli Lilly


Akebia


Supponor


Astronics


Lenovo


Solvay


Principaux dossiers


  • Represented Amazon in proceedings concerning a potential interim licence and FRAND rate setting proceedings in the UK.
  • Defended Supponor against infringement allegations at the first hearing before the Helsinki division of the Unified Patent Court (UPC), resisting applications for preliminary and permanent injunctions.
  • Representing BMS in two patent disputes concerning its blockbuster anticoagulant medicine Eliquis against Two generic drug Teva and Sandoz.

Osborne Clarke LLP

Osborne Clarke LLP‘s patent group works under the leadership of experienced litigator Arty Rajendra, routinely acting for clients in innovation-driven sectors in contentious and non-contentious respects, including running biosimilars litigation, life sciences product launch strategies, SEP and FRAND disputes, IP-rich transactions, licensing matters, and more. Will James advises on strategy and acts for tech-driven companies, such as those in the medical devices, electronics, and life sciences spaces, in disputes. Tim Harris is engaged in a wide range of pharma, biotech, and life sciences litigation, and Trevor Crosse specialises in biopharmaceutical patent and SPC litigation, and helps clients to enforce and commercialise their rights.

Responsables de la pratique:

Arty Rajendra


Autres avocats clés:

Will James; Tim Harris; Trevor Crosse


Les références

‘Strong team engagement from senior partner to junior assistant.’

‘Versatile and always on the ball.’

‘Will James and Tim Harris are very responsive and creative. They leave no stone unturned.’

‘Osborne Clarke brings tremendous expertise in all aspects of patent litigation to complex matters of great importance. They are able to bring a global perspective to UK matters that take into account legal intricacies and business considerations.’

‘Arty Rajendra is extremely driven, knowledgeable about her field, and committed to her clients and cases.’

Principaux clients

Amgen


PanOptis


Avanci


Kantar Group


OMERS Life Sciences


Santen


Innovius


Anstar Limited


Principaux dossiers


  • Advised Avanci in FRAND proceedings brought by Tesla.
  • Advised OMERS Life Sciences in relation to its acquisition of a portion of Enanta Pharmaceuticals’ royalty entitlement for the antiviral medication Maviret (glecaprevir).
  • Advised Amgen in patent revocation and infringement proceedings against Janssen relating to Amgen’s biosimilar version of the anti-IL12/IL23 antibody ustekinumab.

Linklaters LLP

The patents practice at Linklaters LLP is focused on handling large-scale, patent-rich transactions and commercial deals for a stellar client list covering the life sciences, consumer, tech, and automotive sectors. Yohan Liyanage advises on major transactions and joint ventures as well as patent litigation, and Katie Coltart spearheads the team’s contentious offering, handling patent licensing disputes, biosimilars litigation, SEP and FRAND work, and revocation actions in the tech space. Paul Joseph is another key contact for transactional matters, and Ian Karet contributes significant experience in various streams of IP litigation and non-contentious commercial instructions.

Responsables de la pratique:

Yohan Liyanage; Katie Coltart; Paul Joseph; Ian Karet


Principaux clients

Playtech Software Limited


GSK (Tesaro)


Sony


Volkswagen AG


Theramex


Vodafone


Verizon


Deutsche Telekom


Telefonica


Orange


AT&T


T-Mobile


Rio Tinto plc


iCON Infrastructure


Ellison Institute of Technology


Siemens Healthineers


Tate & Lyle


Brookfield


Principaux dossiers


  • Representing Playtech in patent proceedings involving a Playtech patent relating to an online gaming system, which is alleged by OnAir Entertainment to be invalid in revocation proceedings brought before the Paris Central Division of the UPC.
  • Advised Tesaro in Court of Appeal proceedings in respect of a dispute with AstraZeneca concerning allegedly unpaid royalties under two pharmaceutical patent licences.
  • Advised Volkswagen on its 50-50 joint venture with Rivian to create electrical architecture and automotive software, for use in both companies’ future electric vehicles.

Marks & Clerk

Life sciences and chemicals litigator Mike Gilbert and mechanics, electronics, software, and telecoms dispute expert Dafydd Bevan head up the patents side of IP boutique Marks & Clerk, which acts for an impressive life sciences client base in a range of actions, including those involving the UPC. The team, which includes enforcement, defence, and commercialisation specialist Charlie Balme, also advises companies in the telecoms, pharmaceuticals, and machinery sectors on transactions and commercial agreements. Daniel McGrath is a key litigator on the team, and Marcus Riby-Smith advises on both commercial matters and disputes.

Responsables de la pratique:

Mike Gilbert; Dafydd Bevan


Autres avocats clés:

Daniel McGrath; Marcus Riby-Smith; Tom Taylor, Mari Brace, Caitlin Ahern; Charlie Balme


Principaux dossiers


  • Instructed by Pfizer in a three-patent revocation action against GSK relating to GSK’s patents concerning features of RSV vaccines.
  • Instructed by Meril Life Sciences to assist incumbent firms with ongoing litigation before the UPC and in the UK.
  • Advising Sumi Agro in connection with preliminary injunction proceedings.

Mishcon de Reya LLP

Seasoned practitioner David Rose leads the IP offering at Mishcon de Reya LLP, which handles contentious and non-contentious instructions for a varied client list. The substantial team includes litigator Campbell Forsyth, who has acted for clients in various innovation-based industries, handling SEP and FRAND litigation, major disputes concerning generic drugs, and patent strategy work. Patrick Farrant‘s remit includes advising life sciences entities on a variety of transactions, and Jeremy Hertzog litigates across the full suite of IP rights, with particular expertise in obtaining and defending injunctive relief. Gareth Dickson focuses on software, database, design rights, and domain names, and Peter Nunn is well-versed in cases concerning patent infringement and licensing issues, and trade secrets. Longstanding patents specialist Justin Lambert is another key resource for clients, as is Conor McLaughlin, whose caseload spans patent prosecution, strategy, and contentious proceedings. Litigator James Holland and tech and life sciences contracts lawyer Anna Sloan are further assets in the group.

Responsables de la pratique:

David Rose


Autres avocats clés:

Campbell Forsyth; Jeremy Hertzog; Patrick Farrant; Gareth Dickson; Peter Nunn; Justin Lambert; Connor McLaughlin; James Holland; Anna Sloan


Les références

‘David Rose holds his nerve against all odds, and gets financial results that exceed expectations.’

‘We were provided with an extremely high quality of service backed by a wealth of knowledge in the area. They gained our trust immediately – absolutely crucial when dealing with high-stress, high-pressure, high-risk legal situations. They excelled at understanding our case and how they could help us, and provided us with a roadmap out that benefitted us long-term. They listened to and understood our concerns and were patient when we didn’t understand. As a company, we wouldn’t go elsewhere and would recommend the team wholeheartedly.’

‘Campbell Forsyth has an almost unrivalled knowledge of the field, and we felt instantly at ease with him representing us. Talking through situations, Campbell comes up with smart strategies and ideas on the spot that are excellent arguments and also commercially beneficial.’

Principaux clients

Aylo Premium Limited


DIOsynvax


Dr Reddy’s Laboratories (UK) Limited


Heraeus Noblelight Limited


Hotpod Yoga Limited


Luye Pharma


Relation Therapeutics


Positec


Zentiva


Zuru Inc


Principaux dossiers


  • Acting for Aylo Premium and others in UK High Court and related Unified Patent Court cases in a multi-jurisdictional high-tech patent dispute.
  • Acting for Luye Pharma in revocation proceedings relating to a patent for a transdermal patch containing Rotigotine.
  • Advising Relation Therapeutics on two multi-programme strategic collaborations with GSK, in connection with the identification and validation of novel therapeutic targets for fibrotic disease and osteoarthritis.

Stephenson Harwood

Supporting clients with contentious and non-contentious patent-related issues, Stephenson Harwood’s IP department is capable in various sectors, including the emerging technologies and life sciences spaces. Practice head Alexandra Pygall assists clients with patent licensing, partnering, collaboration, R&D, and other agreements, as well as anti-counterfeiting and enforcement issues. Rob Jacob specialises in cross-border litigation, and Naomi Leach’s interests include patent commercialisation. Also on the team are experienced litigator Helen Conlan, and Laura Elliott, who concentrates on life sciences contract disputes.

Responsables de la pratique:

Alexandra Pygall


Autres avocats clés:

Rob Jacob; Naomi Leach; Helen Conlan; Laura Elliott


Les références

‘The team is just outstandingly good. It has evolved extremely well over the last years. They are extremely responsive and very nice to work with. They always go the extra mile and also offer services tailored to clients’ needs at short notice.’

‘Rob Jacob is an impressive litigator and a trusted adviser.’

‘The team provides valuable strategic counsel which is commercially relevant to our needs. I know that I can rely on the team to be up-to-date with new technical developments in the field. The team are really responsive.’

Principaux clients

GlaxoSmithKline Plc


Haleon Plc


Johnson & Johnson Innovation Limited


BioNTech SE


Marks & Spencer Plc


Katjes Fassin GmbH


easyGroup Limited


GAP, Inc.


Bicycle Therapeutics


Ancestry.com


Duracell Group


Oxford Biomedica


BenevolentAI


MFS Africa


The Dr Wolff Group


Shield Therapeutics Plc


Acacia Pharma


Novacyt AS


NL Holdings (Niki Lauda Family Trust)


Perfetti van Melle


GroundTruth Global Ltd


Stochastico Limited


BXT Accelyon


The People’s Partnership


UCB


Armacell Group


Wiggin LLP

The team at Wiggin LLP advises clients across all IP rights, handling SPC appeals, patent disputes, plant breeders’ rights, patent licensing work, and research-related transactions and agreements in the automotive, biotech, electronics and medical devices fields. Sara Ashby leads the offering, which is strengthened by Michael Browne, who is experienced in both contentious and transactional work, and Calum Smyth, whose interests include tech and software mandates. Georgina Hart is another name to note.

Responsables de la pratique:

Sara Ashby


Autres avocats clés:

Michael Browne; Calum Smyth; Georgina Hart; Sinclaire Schafer


Les références

‘This is a leading IP practice with some exceptional practitioners. The lawyers are very experienced in both contentious and non-contentious matters. They are commercially oriented and provide effective solutions to complex legal disputes.’

‘Calum Smyth is a truly excellent patent litigator. He brings to Wiggin LLP an unrivalled breadth of knowledge in law and client management. He shows technical flair and is able to embrace new and complex technical areas, including fintech and software patentability.’

‘Sara Ashby is a superb team leader and has an enviable record as a litigator in all areas of IP. Sara has a razor-sharp legal brain, but is still very commercial and client-focused. These qualities, together with her determination in litigation to get the best results for her clients, mean that she is in great demand. Sara is able to turn her hand to a range of different subject-matter areas, from patents to trade marks.’

Principaux clients

Entain


Permavent


Sage Group Plc


Thought Machine Group Limited


Halozyme


BPW


Principaux dossiers


  • Representing a client in patent litigation against Touchlight Genetics.
  • Represent Halozyme, Inc. in its appeal of a UK Intellectual Property Office decision rejecting applications for SPCs in respect of the combination products (1) trastuzumab and recombinant human hyaluronidase and (2) rituximab and recombinant human hyaluronidase.

WilmerHale

With notable SEP and FRAND-related experience, the IP group at WilmerHale offers services across the full array of intellectual property matters to clients in sectors such as the tech and life sciences spaces. The team of patent litigators is jointly led by a team of four: Justin Watts, who is sought out to untangle matters at the intersection of competition law and IP; Anthony Trenton, a seasoned solicitor advocate; Matthew Shade, who handles a varied list of patent disputes; and ‘intelligent and strategic litigator’ Annsley Merelle Ward, who is well-versed in complex cross-jurisdictional litigation.

Responsables de la pratique:

Justin Watts; Anthony Trenton; Matthew Shade; Annsley Merelle Ward


Autres avocats clés:

Delicia Clarke; Alex Calver; Emma Irwin; Mari Sierra


Les références

‘Very strong IP team.’

‘Annsley Merelle Ward – partner with excellent skills across the board and exceptional client commitment.’

‘Anthony Trenton – astute operator.’

Principaux clients

Bristol-Myers Squibb


Schlumberger (SLB) / Gyrodata, Inc.


Moderna


Arnold & Porter

Litigator and SPC specialist Beatriz San Martin heads the life sciences-focused operation at Arnold & Porter, which has handled a long list of research and development projects, partnership, licensing, and collaboration agreements, M&A, and more for key innovators in the pharma space. Notably experienced in vaccine-related work, Ewan Townsend handles transactional mandates for a range of pharma clients, assisting with the development, exploitation, and commercialisation of medicinal products as well as delivering regulatory advice. Also on the team is Tom Wilson, who focuses on transactions.

Responsables de la pratique:

Beatriz San Martin


Autres avocats clés:

Ewan Townsend; Tom Wilson


Les références

‘Ewan Townsend is excellent.’

‘They are very approachable and build strong relationships with clients.’

‘They not only give excellent strategic and commercial advice, but do so in a straightforward way.’

Principaux clients

Cognizant


Pfizer


Touchlight


Norgine


Essential Pharma


AstraZeneca


Alnylam


Amicus


Principaux dossiers


  • Advising Touchlight on an agreement and a long-term collaboration for the development and manufacture of new dbDNA vaccines and therapeutics across a broad range of animal health indications.
  • Advising Norgine on an exclusive license with Fennec Pharmaceuticals in respect of PEDMARQSI®, the only approved therapy in the EU and U.K. for the prevention of ototoxicity induced by cisplatin chemotherapy in patients one month to 18 years of age with localised, non-metastatic solid tumours.
  • Advising AstraZeneca on a new framework agreement under which CEPI will provide funding of up to $45m for the development of vaccines, biologics, or other medical counter-measures, including a multi-specific pandemic influenza vaccine utilising AZ’s proprietary VHH antibody platform.

DLA Piper

Ruth Hoy heads the patents practice at DLA Piper, which has taken on major disputes in the consumer electronics and tech sectors, and acts for a broad client base spanning the life sciences, energy and automotive sectors, among others. The group also assists clients with transactional matters such as commercialisation, licensing, and strategy issues, and a range of disputes, including SEP and FRAND matters, where Deborah Bould is highly recommended. ‘Brilliant tactician’ Rebecca Lawrence focuses on life sciences matters, and Tabitha Norris advises clients on development projects, licensing work, SEPs, and registered designs in innovation-rich sectors.

Responsables de la pratique:

Ruth Hoy


Autres avocats clés:

Deborah Bould; Rebecca Lawrence; Tabitha Norris


Les références

‘DLA Piper has a very strong practice in the field of patents. They have a number of partners with a great depth of experience in technical patent litigation.’

‘Rebecca Lawrence is a brilliant litigator with very wide experience in life sciences and other technical patent disputes. She is a brilliant tactician and always produces great outcomes for clients.’

‘DLA Piper understands our risk appetite and the industry in which we work. The firm adopts a commercial approach by proactively providing legal services around our needs. Their patent advice, provided primarily through Deborah Bould, is unrivalled, meaning we would simply not be prepared to look elsewhere for patent advice.’

‘DLA Piper’s Deborah Bould has advised our business for more than 20 years. This alone serves as a testament to her abilities and the value the business places on her judgement and expertise in the patents sphere. Put simply, Deborah is our « go-to » lawyer; there is nobody else in the market we would be prepared to take advice from in this area. Her innate ability to identify and resolve issues in a timely and thorough manner makes her invaluable to the business.’

‘Tabitha Norris is a keen, dedicated, and highly skilled lawyer who demonstrates both commercial flair and confidence in providing advice to our business. She is thoroughly prepared and is comfortable providing advice to non-lawyers, explaining complex issues and potential repercussions with ease, allowing colleagues to grasp points quickly.’

‘Ruth Hoy is a knowledgeable and experienced partner who has a very strong strategic grasp of IP matters and complex commercial litigation. Deborah Bould and Rebecca Lawrence run a substantial and respected patent litigation team who bring understanding and insight to all they do.’

Principaux clients

ADM Group


British Airways


Cancer Research UK


Cancer Research Horizons


Corre Energy


Currys


Dexcom


Elekta


Euro Caps


GE Vernova


Honeywell


LG Electronics


NetNumber


Premier League


ResMed


RPS Group


Safestand Limited


Sopra Steria


Unilever


University of Sheffield


Wood Mackenzie


Principaux dossiers


  • Acting in High Court and Court of Appeal litigation for Safestand concerning alleged infringement of their patents and registered designs by a competitor.
  • Advising Cancer Research UK on various matters, including patent transactional issues, exemptions from patent infringement and potential patent licensing issues.
  • Providing patent-related support for the spin-off of GE Vernova, GE’s portfolio of energy businesses, from GE.

Keystone Law

The large intellectual property outfit at Keystone Law receives instructions from clients hailing from various innovation-based sectors and supports clients with their contentious and commercial IP needs, including SEP/FRAND matters, digital asset protection, patent infringement work, IP strategy, transactions, and more. Team members include Rebecca Halford–Harrison, who handles patent issues in chemistry and formulation-based industries such as the food and beverage, cosmetics, life sciences, and electronics spaces. Simon Chalkley advises brand, creative, and tech-driven companies on transactions, strategy, and disputes, while Robert Pocknell specialises in telecoms work. James Tumbridge and Robert Peake arrived from Venner Shipley LLP in 2024.

Autres avocats clés:

Rebecca Halford–Harrison; Simon Chalkley; Robert Pocknell; James Tumbridge; Robert Peake


Les références

‘The practice is able to provide expertise in multiple areas of law.’

‘I work closely with Stuart Darlington and Laurence Grey whom I find to be outstanding within their fields. They are always accessible and react swiftly when matters require it.’


Principaux clients

Comfort Click Limited


Datecs OOD


TH2 Designs


Tangle Inc


Zuru Inc


Porcelain Tiles Limited


Principaux dossiers


  • Advised Comfort Click Limited with regard to patent infringement proceedings threatened by Actegy Limited.
  • Advising Porcelain Tiles Limited on a dispute in the High Court with Granitifiandre.

Venner Shipley LLP

Following its merger with AA Thornton, the expanded patents team at Venner Shipley LLP advises a range of multinational household names on patent and SEP prosecutions, applications, oppositions, appeals, and infringement actions, with vast experience across innovative sectors such as the pharmaceuticals and software, tech, and telecoms spaces. The group, which includes IP barrister Daniel Byrne and key tech contact Simon Taor, is led by Geoff Hussey, whose experience spans the commercial exploitation of intellectual property rights, and disputes. Craig Turner is another key contact in the practice.

Responsables de la pratique:

Geoff Hussey


Autres avocats clés:

Daniel Byrne; Simon Taor; Craig Turner


Les références

‘I have had the opportunity to work with the patents team at Venner Shipley on several matters, and I have consistently been impressed by their ability to combine deep legal expertise with practical, innovative thinking. They are highly responsive, client-focused, and particularly adept at finding pragmatic solutions to complex legal issues.’

‘Their hands-on, commercially minded approach makes them a valuable partner, especially in high-stakes or cross-border contexts. They are extremely skilled at navigating multi-jurisdictional disputes and coordinating strategy across different legal systems—always with clarity, precision, and strategic foresight.’

‘I would especially recommend Dan Byrne. He is a brilliant legal expert with a remarkable ability to think outside the box. Dan’s science degree also gives him a solid grasp of technical subject matter, which is a real asset in patent cases. Dan is not only technically excellent, but also a pleasure to work with: thoughtful, approachable, and fully committed to achieving the best possible outcomes.’

Principaux clients

AB Agri


Aristo Pharma GmbH


Biocon Biologics


CellmAbs


Cipla Limited


Dr Reddy Laboratories


NatureMetrics


Geobrugg AG


Novartis


Oil States International Inc.


Robert Bosch GmbH


SUN Pharma


Unichem


Sanofi


The Procter & Gamble Company


Zaun Limited


No Climb Products Limited


Principaux dossiers


  • Acting for No Climb Products Limited against Gas Safe Europe Limited in a patent infringement claim in the Intellectual Property Enterprise Court.
  • Acting for Betafence against Zaun in a Patents Court case relating to the technical function of a high security fence post.

Clyde & Co

The IP group at Clyde & Co specialises in representing generic drug producers in patent proceedings, and defending patent attorneys facing negligence claims. Ralph Cox, who serves as practice lead, has over two decades of experience with life sciences clients in a range of disputes, and Chris Williams is a key contact for marine, energy, and natural resources companies.

Responsables de la pratique:

Ralph Cox


Autres avocats clés:

Chris Williams


Cooley (UK) LLP

Colm Murphy leads Cooley (UK) LLP‘s patent offering, which is adept at navigating licensing and collaboration agreements for emerging life sciences and biotech innovators, as well as advising those who invest into the sectors. The team, which includes patent strategy and application specialist Tanya Heare-Rowlands and partnership and collaboration agreement-focused Joe Sandys, also handles the IP elements of M&A.

Responsables de la pratique:

Colm Murphy


Autres avocats clés:

Tanya Heare-Rowlands; Joe Sandys


Principaux clients

Ligand Pharmaceuticals


Illumina, Inc.


Kohlberg Kravis Roberts


Hummingbird Biosciences


Mestag


Anocca


Apollo Therapeutics


Bavarian Nordic


Adcendo ApS


AviadiBio


Forbion


Principaux dossiers


  • Advised Ligand Pharmaceuticals on the IP-related aspects of its acquisition of Apeiron Ag for $100m.
  • Advised KKR on the IP-related aspects in its joint acquisition, together with Impilo, of Immedica Pharma.
  • Advising Hummingbird on a licence out of patents and know how covering its ADC technology to US life sciences company, Endeavor.

Gowling WLG

Gowling WLG‘s patent team offers a wide array of services to clients in the life sciences, tech, consumer electronics, and other inventive sectors. Led by Kate Swaine, the team comprises UK patent litigation head Huw Evans, seasoned life sciences lawyer Patrick Duxbury, and biotech and pharma-focused Luke Kempton, who is a key contact particularly for Japanese companies seeking advice on acquisitions, licensing, and other transactions. Paul Inman is regarded for his experience acting for major life sciences clients in disputes, and Sharmela Kalmer advises tech and life sciences companies on non-contentious matters, while resident SEP and FRAND specialist Alexandra Brodie is highly recommended. Christopher Freeth, Andrew Maggs and Alex Driver are further key figures.

Responsables de la pratique:

Kate Swaine


Autres avocats clés:

Huw Evans; Patrick Duxbury; Paul Inman; Luke Kempton; Sharmela Kalmer; Alexandra Brodie; Alex Driver; Christopher Freeth; Andrew Maggs


Les références

‘Strength in depth. They have good partners (Huw Evans and Alexandra Brodie) but a lot of good associates too, across a range of technologies from mobile phones to mechanical inventions.’

‘Huw Evans gets stuck into detail. Alexandra Brodie is good on strategy and with clients. Andrew Maggs is bright and hardworking.’

‘Gowling has a solid patents team with experience, legal knowledge, and technical capability across its breadth.’

Jones Day

The team at Jones Day is led by ‘shrewd’ and seasoned patent disputes specialist Alastair McCulloch, and has experience representing multinational companies in infringement disputes, counseling pharma and biotech clients, and handling SEP/FRAND issues in the tech and telecoms sector. Tech patent expert Toby Sears arrived from CMS in October 2024, expanding the team’s offering in this area.

Responsables de la pratique:

Alastair McCulloch


Autres avocats clés:

Toby Sears; Jonathon Little; Andrew Aistrup; Alex Exact


Les références

‘Alastair McCulloch is shrewd, and litigates like a successful chess player. Alex Exact is a junior associate, but already displays decisive and accurate judgment and shows strong promise.’

‘Toby Sears is highly experienced in this sector, with a great “feel”, a commercial approach, and exceptional client and communication skills. He is fantastic with the team. Highly recommended.’

‘Jones Day are a truly forward-thinking firm – always ready with a new perspective or an innovative new approach.’

Principaux clients

Lufthansa Technik AG


Qualcomm Incorporated


Evidium


Ensyn Renewables Inc


Principaux dossiers


  • Represented Lufthansa Technik AG in patent infringement proceedings against Astronics, Panasonic, and Safran Seats since 2017.
  • Represented Ensyn Renewables in three EPO opposition proceedings against three Ensyn patents directed to renewable fuel oil in oppositions brought by Technip Energies and BTG.

Lewis Silkin

Providing services in filing and prosecution, transaction assistance, and litigation advice related to the full suite of IP rights, Lewis Silkin houses a team led by Tom Gaunt, whose remit spans patent litigation in the mechanical, electrical, and software spaces. The practice’s diverse client base includes a notable number of APAC-based companies. The group includes patent attorney and litigator Andy Cloughley, and Paul Williams, who handles instructions related to chemicals, life sciences products, and mechanical patents, including opposition, infringement, and validity work. Jonathan Hewett specialises in electronics and engineering patents.

Responsables de la pratique:

Tom Gaunt


Autres avocats clés:

Andy Cloughley; Paul Williams; Jonathan Hewett


Les références

‘Lewis Silkin has a team of experts covering all aspects regarding IP and patent matters. We don’t need to worry about anything and things are handled well.’

‘Paul Williams is the patent attorney who has been assisting us with a patent filing and other patent related issues incurred during the time. He is very organised and thus things have gone smoothly. Throughout, we have been clear about the procedures & timelines and provided with detailed information required for decision-making.’

‘The Lewis Silkin team have been very helpful and supportive with our patent applications. They keep on top of the timings and everything is kept in order. They are a pleasure to work with.’

Principaux clients

Aptiv Technologies Limited


Ørsted Wind Power A/S


Sentcell Limited


TDK Lambda


Seiko Epson Corporation


Ichikoh Industries Ltd


Graco Minnesota Inc


Britvic Soft Drinks Limited


Janssen Pharmaceutica NV


Wesco International


Medline


Kokusai Co.


Principaux dossiers


  • Assisting a childcare products company with the transfer and rationalisation of a patent portfolio following its acquisition.
  • Providing Britvic with competitor analysis and strategic advice to map out a series of patent filings and guide future research into a variety of technical streams associated with the patent filings.
  • Advising Bridea Medical BV and Bridea IP BV in relation to a dispute concerning the infringement of the client’s patent by UK-based Vernacare and its subsidiary company Robinson Healthcare’s speculum product.

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Paul, Weiss, Rifkind, Wharton & Garrison LLP‘s London office houses an active non-contentious IP offering, handling large-scale patent-driven transactions, investments, and M&A for clients in the life sciences, tech, retail and consumer sectors, and more, as well as advising clients on matters concerning plant varieties and franchising issues. John Patten leads the group, supported by Alex Zapalowski.

Responsables de la pratique:

John Patten


Autres avocats clés:

Alex Zapalowski


Principaux clients

GSK


TDR Capital


G-III Apparel Group, Ltd.


TRU Kids, Inc.


General Atlantic


WHP Global


KPS Capital Partners


Brighton Park Capital


Global Auto Holdings Limited (GAHL)


Vitruvian Partners


Potter Clarkson LLP

Jointly led by Mark Kramer, who represents a varied client list across all courts, Nick McDonald, and Richard Roberts, who split their time between London and Nottingham, the patents team at Potter Clarkson LLP acts for well-established companies and individuals in pharma, life sciences, tech, and telecoms patent litigation, and advises on transactional mandates, from R&D agreements to joint ventures. Mark Nichols focuses on AI issues. Peter Finnie, especially recommended for his work with startups, is another name to note.

Responsables de la pratique:

Nick McDonald; Richard Roberts; Mark Kramer


Autres avocats clés:

Mark Nichols; Peter Finnie


Les références

‘Regular collaborative meetings. An excellent and knowledgeable team.’

‘Excellent level of diligence and understanding of our company. Also, emphasis on looking ahead, not just working on the short-term.’

Principaux clients

Battle Kart Europe SA


Cloud Cycle Ltd


TrailerLogic LLC


ITM Power


Principaux dossiers


  • Representing Battle Kart Europe SA in active litigation involving patent infringement and a breach of confidence by a competitor.
  • Representing a client in an appeal out of the Comptroller of Patents’ decision to refuse a patent application for inventions arising out of AI, DABUS.
  • Advising TrailerLogic in litigation concerning its patent for its collapsible and adjustable racking for the storage of cadavers.

Reed Smith LLP

Elle Todd heads the patent-focused team at Reed Smith LLP, which takes on a range of contentious and non-contentious instructions from various innovation-driven clients. Litigator Jonathan Radcliffe has experience in FRAND disputes, and the ‘highly knowledgeable’ Philip Thomas‘ practice centres around advising hi-tech companies on strategic and transactional matters at the intersection of data, tech, and IP.

Responsables de la pratique:

Elle Todd


Autres avocats clés:

Jonathan Radcliffe; Philip Thomas; Joshua Schuermann


Les références

‘Great team – work well to produce innovative solutions for clients.’

‘Joshua Schuermann is brilliant to work with. He has a strategic approach and adopts a sensible stance in litigation, producing excellent results for his clients.’

‘Reed Smith were very attentive to our IP business needs, understood clearly the subtleties, what we were wishing to achieve, and how to express and articulate our needs into a formal legal agreement.’

Principaux clients

Kigen (UK) Ltd


Notcoin LLC


House of Cheatham, Inc.


The Black Curriculum


Cambridge Literary Festival


Young Minds


Stevens & Bolton LLP

Under the leadership of versatile IP practitioner Tom Lingard, the patents group at Guildford-based firm Stevens & Bolton LLP specialises in international patent licensing deals, routinely receiving instructions from clients in the life sciences and pharmaceuticals sectors, and other innovative industries. The team, led by Charlotte Tillett, also advises on trade secrets, patent infringement, and know-how disputes, as well as on matters of commercialisation and the sale and purchase of IP. Tom Collins is another key team member.

Responsables de la pratique:

Tom Lingard


Autres avocats clés:

Charlotte Tillett; Tom Collins


Les références

‘The team at Stevens and Bolton are very client-centric, responsive, and competent. They have a very broad range of services, so you can usually get all that you need from their team.’

‘Charlotte Tillett has shown exceptional support over many years. She takes time to understand her clients and always responds efficiently and effectively. She is a pleasure to work with, and the broader team are all exceptional.’

‘A great law firm based in Guildford. Tom Lingard and the team are very responsive, friendly, and professional. I refer an increasing number of IP matters to them when they are outside my own area of IP expertise.’

Principaux clients

Insud Pharma SLU


Lonza Biologics plc


mAbxience Research, SL


Mediq Healthcare UK Ltd


Esteyco S.A.


Principaux dossiers


  • Acted for mAbxience on its strategic global partnership with Teva for the in-licensing of an oncology biosimilar candidate.
  • Advised Esteyco S.A. on a patent and technology licence to a company aiming to create an unconventional wind farm off of the UK coast.
  • Supporting a global biotech company in relation to its patent and knowhow licensing on an ongoing basis.

Charles Russell Speechlys LLP

The team at Charles Russell Speechlys LLP‘s caseload includes IP-rich transactions, M&A, software licensing deals and supply agreements, acting for a diverse client base. Experienced trade marks, copyright and design specialist Mary Bagnall leads the team, which includes Caroline Young, a practitioner focused on transactions and tech-centred work.

Responsables de la pratique:

Mary Bagnall


Autres avocats clés:

Caroline Young


Les références

‘Charles Russell Speechlys LLP offers clear advice in a transparent, professional and friendly manner.’

‘Caroline Young – Caroline shows great expertise in her field and provides concise advice, explaining everything in a clear and easily digestible manner. In our interactions, she is always friendly and well-organised – and an absolute pleasure to work with; Caroline is heartily recommended. A superb adviser.’

Principaux clients

Chuckling Goat


Rentschler


Oncam Global


Apacor


Dementia UK


Puma Investments


Global Canopy


Acora


Sage Group


Conferma


Principaux dossiers


  • Advised Synhelion on various corporate and commercial projects.
  • Advised Microba Life Sciences Limited on its acquisition of Invivo Clinical Limited.
  • Advised the founders of Observe Technologies on its acquisition by AKVA Group.

Fieldfisher

Tommy McKenna heads up the patent group at Fieldfisher, which has experience advising on various IP issues, from patent infringements to parallel imports, and has a notable focus on medical devices and tech issues. Supporting McKenna is Christopher Leung, who handles an array of IP matters, from SPCs to passing off work. Victoria Bentley joined from Shoosmiths LLP in March 2025, bringing significant tech and life sciences litigation experience to the practice.

Responsables de la pratique:

Tommy McKenna


Autres avocats clés:

Victoria Bentley; Christopher Leung


Les références

‘Deep experience in relevant area of litigation law. Capable and committed lawyers.’

‘Calm, considered advice. Litigation can be stressful, and it is important to have advisers who can take the heat out of the situation.’

‘I have worked with individuals from the Fieldfisher team for a number of years. A highly experienced and engaged team who can handle the full range of patent disputes extremely effectively.’

Principaux clients

MGA Entertainment


Principaux dossiers


  • Advising MGA Entertainment in defending claims of unjustified threats of patent infringement and parallel competition law claims.

Norton Rose Fulbright

Non-contentious IP specialist Mike Knapper and tech disputes lawyer Jonathan Ball lead the IP offering at Norton Rose Fulbright, attracting clients operating in the fintech, retail and consumer, transport, and natural resources sector. Recent matters have featured licensing issues, patent litigation, and IP protection strategies.

Responsables de la pratique:

Mike Knapper; Jonathan Ball


Les références

‘A quality team for patent work.’

‘Jon Ball is great to work with. A team player who is very personable and good with clients.’

Principaux dossiers


  • Representing NXP Semiconductors N.V. in a patent litigation case filed by MIMO Research, LLC.

Shoosmiths LLP

With Andrew Brennan at the helm, the patent practice at Shoosmiths LLP advises an array of clients, notably those in the medical devices, tech, and automotive spheres, on various patent issues, from FTO projects, to patent infringement claims, licensing deals, and IP strategy. The team includes litigator Antony Craggs, and life sciences specialist Graham Burnett-Hall.

Responsables de la pratique:

Andrew Brennan


Autres avocats clés:

Antony Craggs; Graham Burnett-Hall; Eloise Di Pasqua


Les références

‘Antony Craggs – great leadership, motivates people, also gets stuck in, plenty of common sense. Victoria Bentley – similar to Antony, with a great knowledge of the law and good strategic judgment. Eloise Di Pasqua is hardworking.’

‘Highly professional team who took the time to understand the technical aspects and work through complex contract negotiations to achieve a timely and satisfactory outcome.’

‘They consistently provide realistic, practical advice, with a broad perspective.’

Principaux clients

Little Lion Entertainment


University of Nottingham


iSmart Ltd


Oxilio


Pharmacosmos


Capita Plc


Cranfield University


Brightwake


Integral Powertrain (Helix)


Bugatti Automobiles SAS


Volkswagen Group United Kingdom Limited (VWG)


Mercedes Benz


Principaux dossiers


  • Advising Little Lion Entertainment on a claim by BattleKart and associated counterclaim for patent invalidity.
  • Advising a client in a High Court claim by Crypto Open Patent Alliance.
  • Advising the client and its international subsidiaries following assertions of patent infringement by BSN Medical GmbH in relation to a key product in the client’s medical device portfolio.